Overview

The National Heart Centre Singapore (NHCS) is involved in a wide range of cardiovascular research projects and clinical trials to improve diagnostic and therapeutic modalities for our patients. The National Heart Research Institute Singapore (NHRIS) was established to bring cardiovascular research to new heights through NHCS' strategic collaboration with the Duke-NUS Cardiovascular and Metabolic Disorders Signature Research Programme.

The NHRIS seeks to transform cardiovascular medicine via the power of basic and clinical research. NHCS has also embarked on the Academic Medicine journey with the introduction of the Cardiovascular Academic Clinical Programme, which seeks to improve the lives and outcomes through enhanced patient care, education and research.

Our Vision

Transforming cardiovascular outcomes through patient-centred research.

Our Mission

To use innovative approaches to identify disease mechanisms and to combine this knowledge with medical technologies and clinical research to prevent and treat cardiovascular disease.

Research Structure

updated org chart.png

Recent News

Murmurs Pulmonary Arterial Hypertension: Not The High Blood Pressure You Know If someone feels more tired than before, finds it harder to climb stairs, or sometimes experiences dizziness or chest tightness, these everyday symptoms should not be ignored. They could be early signs of a condition called pulmonary arterial hypertension (PAH), which is a type of pulmonary hypertension (PH).

30 Apr 2026 | Murmurs Newsletter Read Story

Murmurs Back To Activity: Exercise After Cardiac Surgery Many patients feel overwhelmed after their heart surgery, particularly when deciding when and how to safely resume physical activity.

30 Apr 2026 | Murmurs Newsletter Read Story

Murmurs Venus P Valve: New Hope For Patients With Congenital Heart Disease Imagine living with a heart condition from birth, undergoing major surgery as a child, and then facing the prospect of another open-heart operation in adulthood. For many adults with repaired Tetralogy of Fallot (TOF), a common congenital heart defect, this has been their reality. But a new treatment option called the Venus P valve is changing that narrative by offering a less invasive way to restore heart function and improve quality of life.

29 Apr 2026 | Murmurs Newsletter Read Story

View All News